CN105816431A - 一种氟氯西林钠掩味颗粒及其制备方法 - Google Patents
一种氟氯西林钠掩味颗粒及其制备方法 Download PDFInfo
- Publication number
- CN105816431A CN105816431A CN201610235145.9A CN201610235145A CN105816431A CN 105816431 A CN105816431 A CN 105816431A CN 201610235145 A CN201610235145 A CN 201610235145A CN 105816431 A CN105816431 A CN 105816431A
- Authority
- CN
- China
- Prior art keywords
- flucloxacillin sodium
- taste masked
- masked particle
- carrier
- flucloxacillin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960004273 floxacillin Drugs 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 title claims abstract 19
- 239000008187 granular material Substances 0.000 title abstract description 12
- 235000019640 taste Nutrition 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 10
- 238000005469 granulation Methods 0.000 claims abstract description 8
- 230000003179 granulation Effects 0.000 claims abstract description 8
- 239000002245 particle Substances 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 11
- 239000012876 carrier material Substances 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229940109275 cyclamate Drugs 0.000 claims description 5
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 5
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 5
- 239000004223 monosodium glutamate Substances 0.000 claims description 5
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims description 5
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 5
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- -1 PVPK30 Polymers 0.000 claims description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229960003943 hypromellose Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 31
- 229940079593 drug Drugs 0.000 abstract description 13
- 235000019658 bitter taste Nutrition 0.000 abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 10
- 230000000873 masking effect Effects 0.000 abstract description 9
- PARMJFIQRZRMHG-VICXVTCVSA-M flucloxacillin sodium monohydrate Chemical compound O.[Na+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl PARMJFIQRZRMHG-VICXVTCVSA-M 0.000 description 40
- 239000000243 solution Substances 0.000 description 36
- 239000002671 adjuvant Substances 0.000 description 13
- 238000001035 drying Methods 0.000 description 12
- 235000011837 pasties Nutrition 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001779 taste bud Anatomy 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- VRAIHTAYLFXSJJ-UHFFFAOYSA-N alumane Chemical compound [AlH3].[AlH3] VRAIHTAYLFXSJJ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000020980 bad eating habits Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610235145.9A CN105816431B (zh) | 2016-04-15 | 2016-04-15 | 一种氟氯西林钠掩味颗粒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610235145.9A CN105816431B (zh) | 2016-04-15 | 2016-04-15 | 一种氟氯西林钠掩味颗粒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105816431A true CN105816431A (zh) | 2016-08-03 |
CN105816431B CN105816431B (zh) | 2018-11-27 |
Family
ID=56526934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610235145.9A Active CN105816431B (zh) | 2016-04-15 | 2016-04-15 | 一种氟氯西林钠掩味颗粒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105816431B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030118654A1 (en) * | 2001-12-07 | 2003-06-26 | B. Santos Joyce Bedelia | Taste masked aqueous liquid pharmaceutical composition |
CN102526007A (zh) * | 2012-01-11 | 2012-07-04 | 山东鲁抗舍里乐药业有限公司 | 一种氟苯尼考掩味制剂及其制备方法 |
-
2016
- 2016-04-15 CN CN201610235145.9A patent/CN105816431B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030118654A1 (en) * | 2001-12-07 | 2003-06-26 | B. Santos Joyce Bedelia | Taste masked aqueous liquid pharmaceutical composition |
CN102526007A (zh) * | 2012-01-11 | 2012-07-04 | 山东鲁抗舍里乐药业有限公司 | 一种氟苯尼考掩味制剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
易建勇,等: "氟氯西林钠掩味颗粒的制备与评价", 《中国现代应用药学》 * |
Also Published As
Publication number | Publication date |
---|---|
CN105816431B (zh) | 2018-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014210103B2 (en) | Pharmaceutical composition with improved bioavailability | |
Sharma et al. | Role of taste and taste masking of bitter drugs in pharmaceutical industries an overview | |
KR0168849B1 (ko) | 피목 조성물 및 그의 제조방법 | |
JPH0778023B2 (ja) | セフロキシムアクセチル経口製剤 | |
JPS63310832A (ja) | エリスロマイシン含有組成物 | |
JP2001511443A (ja) | 抗潰瘍活性化合物を含んでなる経口医薬製剤およびその製造方法 | |
CN106102716A (zh) | 雄激素受体拮抗剂的固体药物组合物 | |
TWI717339B (zh) | 含有著色劑的固體製劑 | |
EP3862318A1 (en) | Porous silica particle composition | |
KR20070007129A (ko) | 안정성이 향상된 고형 제제 및 그 제조 방법 | |
CN1187052C (zh) | 含有司他夫定(stavudine)的持续释放微球 | |
CN105982858A (zh) | 一种阿奇霉素掩味的干混悬颗粒剂及其制备方法 | |
KR100389606B1 (ko) | 프란루카스트를함유하는조립물,그제조방법및프란루카스트의부착응집성개선방법 | |
JPH09194347A (ja) | フィルムコーティング粒剤の製造方法 | |
JP5973170B2 (ja) | 固体分子分散物 | |
CN103877027B (zh) | 一种头孢呋辛酯热熔包衣组合物及其制备方法 | |
JP3797605B2 (ja) | 粒状被覆製剤の製造方法 | |
JP2000103730A (ja) | 服用感が改善された医薬組成物 | |
KR20030011797A (ko) | 맛이 차폐된 과립형 입자 | |
CN105816431A (zh) | 一种氟氯西林钠掩味颗粒及其制备方法 | |
JPH031288B2 (zh) | ||
JPH06100602A (ja) | 経口固形製剤およびその製造方法 | |
US20230016901A1 (en) | Granule in which unpleasant taste is masked and method for producing granule | |
AU2017256184A1 (en) | Pharmaceutical combination composition comprising complex formulations of ivacaftor and lumacaftor and their salts and derivatives, process for their preparation thereof and pharmaceutical compositions containing them | |
US5403594A (en) | Oral spiramycin formulations and method for preparing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180711 Address after: 324000 Rainbow Road 4, Xinxin street, Kecheng District, Quzhou, Zhejiang Applicant after: ZHEJIANG JUTAI PHARMACEUTICAL CO.,LTD. Applicant after: Shanxi Yosemade Pharmaceutical Co.,Ltd. Address before: 324002 Rainbow Road 4, Xinxin street, Kecheng District, Quzhou, Zhejiang Applicant before: ZHEJIANG JUTAI PHARMACEUTICAL CO.,LTD. Applicant before: YOSEMADE PHARMACEUTICAL Co.,Ltd. Applicant before: Shanxi Yosemade Pharmaceutical Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200403 Address after: 324002 Zhejiang province Kecheng District of Quzhou City New Street Rainbow Road No. 4 Patentee after: ZHEJIANG JUTAI PHARMACEUTICAL Co.,Ltd. Address before: 324000 Zhejiang province Kecheng District of Quzhou City New Street Rainbow Road No. 4 Co-patentee before: Shanxi Yosemade Pharmaceutical Co.,Ltd. Patentee before: ZHEJIANG JUTAI PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Flucloxacillin Sodium Flavor Masking Particle and Its Preparation Method Effective date of registration: 20231213 Granted publication date: 20181127 Pledgee: Industrial and Commercial Bank of China Limited Quzhou Qujiang sub branch Pledgor: ZHEJIANG JUTAI PHARMACEUTICAL CO.,LTD. Registration number: Y2023980071111 |